Biovista, one of the world leaders in drug repositioning, is hosting a lunch and panel discussion on “Drug Repositioning in Rare and Orphan Diseases”, October 18th in Washington DC. Interested parties are invited to register. The discussion will involve thought leaders from associations such as CFIDS, Partnership for Cures and FARA and will explore if … Read More
Events
Biovista to host Drug Repositioning Workshop at 2nd World PGX Summit
CHARLOTTESVILLE, Virginia, March 20, 2012 — Biovista announced today that it will be organizing a workshop on drug repositioning at the upcoming World Pharmacogenomics Summit being held April 24-26 in Boston. The Workshop entitled “Understand How to Use PGx in Drug Repositioning, Adverse Event Prediction, Patient Subpopulation Stratification and Personalized Medicine” will help strategic level … Read More
Biovista to present at the Drug Repositioning Conference
CHARLOTTESVILLE, Virginia, June 3, 2011 — Biovista announced today that it is presenting at the Drug Repositioning Conference, San Francisco, on July 13 2011. Biovista’s President, Dr. Aris Persidis, will give a presentation on systematic repositioning using Mechanism of Action. The Drug Repositioning Conference is one of the prime events in this space and has been … Read More
Biovista to present at the 5th World Generic Medicines Congress
CHARLOTTESVILLE, Virginia, February 11, 2011 — Biovista announced today that it is presenting at the 5th World Generic Medicines Congress, London UK, on Thursday 24 February 2011. Biovista’s CEO, Dr. Andreas Persidis, will give a presentation on the business and science of repositioning generic medicines at the 5th annual World Generic Medicines Congress Europe of … Read More
Biovista announces a Webinar on Drug Safety
CHARLOTTESVILLE, Virginia, February8, 2011 — Biovista announced today that it is co-presenting a webinar with FDA/OCP on Predicting Serious Adverse Events Using Mechanism of Action, on Thursday, 24 February 2011. Biovista’s President, Dr. Aris Persidis, will co-present together with Dr. Darrell Abernathy, Associate Director for Drug Safety in the Office of Clinical Pharmacology at the … Read More